57.00
+1.00
+(1.79%)
At close: April 17 at 8:03:52 AM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 11 | 10 |
| Avg. Estimate | 1.62B | 1.76B | 7.16B | 7.58B |
| Low Estimate | 1.58B | 1.7B | 6.94B | 7.23B |
| High Estimate | 1.67B | 1.83B | 7.44B | 8.26B |
| Year Ago Sales | 1.54B | 1.67B | 6.75B | 7.16B |
| Sales Growth (year/est) | 5.68% | 5.34% | 6.04% | 5.88% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 59P.F | -- | -- | -- | -- |
| S&P 500 | 6.92% | 5.09% | 8.78% | 14.15% |
Upgrades & Downgrades
| Maintains | Keybanc: Overweight to Overweight | 4/16/2025 |
| Maintains | Truist Securities: Buy to Buy | 4/14/2025 |
| Maintains | B of A Securities: Buy to Buy | 4/1/2025 |
| Reiterates | Benchmark: Buy to Buy | 2/26/2025 |
| Maintains | Goldman Sachs: Buy to Buy | 2/25/2025 |
| Downgrade | William Blair: Outperform to Market Perform | 2/21/2025 |